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Abstract – Following a severe outbreak of clinical scrapie in 2006–2007, a large dairy goat herd was culled
and 200 animals were selected for post-mortem examinations in order to ascertain the prevalence of infection,
the effect of age, breed and PRNP genotype on the susceptibility to scrapie, the tissue distribution of disease-
associated PrP (PrPd), and the comparative efﬁciency of different diagnostic methods. As determined by
immunohistochemical (IHC) examinations with Bar224 PrP antibody, the prevalence of preclinical infection
was very high (72/200; 36.0%), with most infected animals being positive for PrPd in lymphoreticular system
(LRS) tissues (68/72; 94.4%) compared to those that were positive in brain samples (38/72; 52.8%). The
retropharyngeal lymph node and the palatine tonsil showed the highest frequency of PrPd accumulation (87.3%
and 84.5%, respectively), while the recto-anal mucosa-associated lymphoid tissue (RAMALT) was positive in
only 30 (41.7%) of the infected goats. However, the efﬁciency of rectal and palatine tonsil biopsies taken
shortly before necropsy was similar. The probability of brain and RAMALT being positive directly
correlated with the spread of PrPd within the LRS. The prevalence of infection was inﬂuenced by PRNP
genetics at codon 142 and by the age of the goats: methionine carriers older than 60 months showed a much
lower prevalence of infection (12/78; 15.4%) than those younger than 60 months (20/42; 47.6%); these last
showed prevalence values similar to isoleucine homozygotes of any age (40/80; 50.0%). Two of seven goats
with deﬁnite signs of scrapie were negative for PrPd in brain but positive in LRS tissues, and one goat showed
biochemical and IHC features of PrPd different from all other infected goats. The results of this study have
implications for surveillance and control policies for scrapie in goats.
scrapie / goat / prion disease / transmissible spongiform encephalopathy
1. INTRODUCTION
Scrapie is a progressive and fatal degenera-
tion of the central nervous system (CNS) that
occurs naturally in small ruminants. Scrapie in
sheep was the ﬁrst disease to be recognized
within the group of the transmissible spongi-
form encephalopathies (TSE), which affect sev-
eral mammalian species, including man and
cattle. Naturally-occurring scrapie in goats
was ﬁrst reported in France [5], and although
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this and other subsequent descriptions [3, 16,
34] record contact with scrapie-infected sheep,
some others do not [15, 29, 34]. In most cases,
the disease in goats has been reported to closely
resemble that in sheep, although differences in
clinical manifestation between the two species
have been described [4].
Experimentally, goats are susceptible to
sheep scrapie [27] and to intracerebral or oral
infection with the bovine spongiform encepha-
lopathy (BSE) agent [9]. The goat population
in Europe (around 13 million), and particularly
in Great Britain (around 95 000), is consider-
ably smaller than the sheep population (around
100 and 24 million, respectively [8]), but most
European goats, unlike sheep, are kept for
dairy purposes. Therefore, historically, goats
are more likely than sheep to have been
exposed to the BSE agent in concentrate feed;
this is akin to the relatively higher BSE expo-
sure of dairy cows compared to beef suckler
cattle [32]. Indeed, the ﬁrst naturally-occurring
case of BSE in small ruminants was reported
in a goat in France [6], and another probable
goat case with BSE-like immunohistochemical
(IHC) characteristics has emerged from a retro-
spective study in Scotland1 [19]. However, our
ability to discriminate scrapie from BSE in
goats is hindered by a lack of information
on the range of molecular, pathological and
biological characteristics of natural caprine
scrapie cases.
The susceptibility to scrapie in small rumi-
nants is controlled in part by the primary
sequence of the prion protein gene (PNRP).
This is well established for sheep, but less well
examined for goats [11]. The most common
amino acid polymorphisms in British goat
breeds are at codons 127 (glycine or serine),
142 (isoleucine or methionine), 143 (histidine
or arginine) and 240 (proline or serine), and
an association of polymorphisms at codons
142 and 143 with susceptibility and incubation
period has been reported [1, 2, 10]. A compre-
hensive review of the goat PNRP gene
polymorphisms and their association with dis-
ease has recently been published [31].
Following conﬁrmation of scrapie in a large
herd of dairy goats in the South of England,
the whole herd was culled as required by the
legislation in place at the time. This provided
the opportunity to investigate the effect of
breed, age and PNRP genotype on the
prevalence of infection and tissue distribution
of disease-associated PrP (PrPd), to assess the
efﬁciency of statutory testing methods in the
detection of preclinical infection, and to charac-
terize the clinical signs of the disease. These
data can be used in evaluating strategies for
the management and control of future TSE
outbreaks in goat herds.
2. MATERIALS AND METHODS
2.1. Herd and case history
This herd was created in 1998 with the purchase
of  400 goats from a single herd. Two main addi-
tions to the herd of  100 goatlings each time took
place in 2003 and 2007. This was an intensively
managed, permanently housed dairy herd, which
increased in size progressively to meet the develop-
ing market for goat milk. Consequently, there was a
low cull/replacement policy so, at the time of culling,
it consisted of 1 820 animals, 1 307 of which were
one year and older. Three breeds, the Anglo-Nubian
(66.0%), the Saanen (23.0%) and the Toggenburg
(8.0%), either as pure-breeds or as crosses, accounted
for 97.1% of the stock. No presence of or contact
with sheep was recorded at any time since the crea-
tion of the herd to its culling.
The index case of scrapie on this holding was
diagnosed in a fallen goat in 2005. After conﬁrma-
tion, the herd was put under movement restriction
and monitored closely. Five scrapie cases were
detected up until March 2006, another 20 between
April 2006 and March 2007 and 50 from April
2007 until the herd was ﬁnally culled in March
2008. If only goats older than one year are consid-
ered, the annual incidence of scrapie rose signiﬁ-
cantly from 0.6% in 2005–2006, to 2.4% in
2006–2007 and to 5.0% in 2007–2008.
When the herd was culled, a selection of 200
goats older than 12 months was made, partly on
the basis of their PNRP genotype (120) and partly
at random (80), for the studies detailed below. The
genotype frequencies at codon 142 in these 200 goats
were 40.0% II142, 46.5.0% IM142 and 13.5% MM142
(I, isoleucine; M, methionine).1 Jeffrey and Spiropoulos, unpublished data.
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2.2. Clinical monitoring and biopsy
examinations
The 200 selected goats were transported to
the Veterinary Laboratories Agency facilities in
Weybridge (UK) where they were clinically exam-
ined on arrival. A short examination protocol was
used to assess body condition, posture, locomotion,
behaviour, presence of tremor, pruritus and vision.
Repeated neurological examinations and monitoring
by closed circuit television were conducted in those
goats that were selected for milk collection and/or
monitoring of clinical progression. Following the sys-
tematic clinical assessment protocol described else-
where [22], animals were grouped as: 0, clinically
healthy; 1, no signs of scrapie but of other disease;
2, inconclusive signs (frequent rubbing, tremor or
nervousness); 3, deﬁnite signs of scrapie (evident
signs of pruritus, such as a positive scratch test or
progressive/extensive hair loss in the absence of vis-
ible ectoparasites, with or without tremor, ataxia or
nervousness).
To assess biopsy methods for pre-clinical diagno-
sis, samples were taken from 62 of the 200 goats; 16
of them provided palatine tonsil biopsies, 17 pro-
vided rectal mucosa specimens, and 29 provided
both. Most biopsy samples were collected between
one and two months before euthanasia; exceptionally,
some biopsies were obtained within one week prior
to necropsy or three months before euthanasia. The
methods for palatine tonsil and rectal mucosa biop-
sies have been described by Jeffrey et al. [17] and
by Gonza´lez et al. [14], respectively. Biopsy samples
were examined for the presence of PrPd by the same
IHC method as for post-mortem samples (see below).
2.3. Post-mortem samples and laboratory
examinations
Goats were killed by pentobarbital overdose
injection and exsanguination. The following tissues
were collected at post-mortem and ﬁxed in 10%
formaldehyde: sagittally-sectioned half brain, tho-
racic spinal cord (segments 10–12), distal ileum, pal-
atine tonsil, spleen, nictitating membrane, medial
retropharyngeal, pre-scapular, distal jejunal and
pre-femoral lymph nodes, and recto-anal mucosa-
associated lymphoid tissue (RAMALT).
Immunohistochemical examinations were con-
ducted on all collected tissue samples. In the brain,
routine IHC was only performed in sections of
medulla oblongata at the obex and of diencephalon.
The IHC protocol followed in this study for PrPd
labelling, including antigen retrieval steps, was as
described previously for the PrP antibody R486
[12]. Herein however, caprine tissue sections were
incubated overnight at 27 C with primary antibody
Bar224 (SPIbio, Montigny-le-Bretonneux, France),
which binds to a globular domain epitope of PrP,
and showed good performance for the detection of
carpine PrPd [19]. In goats with a PrPd positive result,
scrapie-BSE discriminatory IHC was carried out on a
selected lymphoid tissue (usually retropharyngeal
lymph node) and a brain section (usually obex).
For that purpose, two serial sections were each incu-
bated with either Bar224 or 12B2 (CVI, Lelystad,
The Netherlands) antibodies; the 12B2 monoclonal
antibody recognizes an epitope in the N terminus of
PrP and gives no signal for intracellular PrPd in cases
of experimental goat BSE [19].
In addition, following a conventional statutory
testing protocol, samples of medulla oblongata cau-
dal to the obex from all 200 goats were analyzed
for PrPres by a rapid test (TeSeE ELISA, Bio-Rad,
France). ELISA positive cases were examined by dis-
criminatory IHC with R145 (VLA, Weybridge, UK)
and P4 (R-Biopharm AG, Darmstadt, Germany) anti-
bodies, by discriminatory Western blotting with
Sha31 (CEA, Saclay, France) and P4 antibodies,
and for evidence of neuropil vacuolation by conven-
tional histological examination. R145 and Sha31
antibodies recognize epitopes in the C-terminal and
globular domains of PrP protein, respectively, and
P4 recognizes an amino acid sequence close to that
bound by 12B2 [18].
Blood or tissue samples from all 200 goats plus
62 of the 75 goats diagnosed with scrapie before
the cull of the herd were taken for PCR ampliﬁcation
and sequencing of the whole open reading frame of
the PNRP gene with primers PS-112d – TGTTTA
TAGCTGATGCCACTGC and PS+50u – CCCCC
AACCTGGCAAAGATTAAGA. Sequencing was
performed on an Applied Biosystems 3130 Genetic
Analyzer with the BigDye terminator v3.1 cycle
sequencing kit as per the manufacturer’s protocol.
3. RESULTS
3.1. Prevalence of infection and post-mortem
testing efﬁciency
Goats were considered scrapie-infected if at
least one of the 12 tissue sections routinely
examined by IHC showed speciﬁc PrPd label-
ling with Bar224 antibody. Based on this crite-
rion, the frequency of infection in the 200
selected goats was 36.0% (72/200), and it did
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not appear to be related to breed, so that it was
42.4% for the Anglo-Nubian (50/118), 26.5%
for the Saanen (13/49), and 27.3% for the Tog-
genburg (6/22); these differences were not sig-
niﬁcant by Fisher’s exact test. Three of 11
goats (27.3%) of other minority breeds and
crosses were also infected.
Four of the 72 positive goats showed PrPd
accumulation only in the brain, 34 only in
lymphoreticular system (LRS) tissues, and 34
in both brain and LRS tissues. A summary of
other laboratory results, PNRP genotype and
age distribution, and clinical status, in relation
to this classiﬁcation based on PrPd distribution
in brain and LRS tissues is given in Table I.
The likelihood of an IHC positive result in brain
was clearly correlated to the range of distribu-
tion of PrPd in LRS tissues (Tab. II). Thus,
while only 9 of 26 goats with three or fewer
positive LRS tissues showed PrPd in the brain,
22 of 31 with seven or more positive LRS tis-
sues did so; these proportions were signiﬁcantly
different in the Fisher’s exact test (p < 0.01).
Therefore, the wider the PrPd dissemination in
the LRS, the higher the likelihood of PrPd accu-
mulating in the brain is.
Only 19 (26.4%) of the 72 scrapie-infected
goats were positive in the BioRad TeSeE
ELISA; in other words, half of those animals
that were positive in the brain by IHC were
Table I. Summary of laboratory results, genotype and age distribution, and clinical status of the 72 scrapie-
infected goats according to their PrPd distribution in brain and LRS tissues.
PrPd IHC positive in
Brain only (n = 4) LRS only (n = 34) Brain and LRS (n = 34)
Other results
ELISA brain (0) 0 (0) (0) 0 (0) (56) 19 (100)
WB brain (0) 0 (0) (0) 0 (0) (56) 19 (100)
Vacuolation (0) 0 (0) (0) 0 (0) (38) 13 (100)
Genotype at 142
II (0) 0 (0) (76) 26 (65) (41) 14 (35)
IM (50) 2 (7) (21) 7 (25) (56) 19 (68)
MM (50) 2 (50) (3) 1 (25) (3) 1 (25)
Age (months)
< 60 (75) 3 (9) (38) 13 (41) (47) 16 (50)
> 60 (25) 1 (4) (62) 21 (61) (53) 18 (35)
Clinical signs
Normal (75) 3 (7) (68) 23 (50) (59) 20 (43)
Other (0) 0 (0) (9) 3 (50) (9) 3 (50)
Inconclusive (25) 1 (8) (18) 6 (46) (18) 6 (46)
Deﬁnite (0) 0 (0) (5) 2 (29) (14) 5 (71)
Results are indicated as number of animals falling in each group. Percentage in brackets to the left of the number
refers to the total of goats in each IHC category (brain only, LRS only or brain and LRS). Percentage in brackets to the
right of the number refers to the total of goats in each set of other results, genotype, age and clinical condition (rows).
Table II. Probability of detection of PrPd in the
brain in relation to the spread of infection in LRS
tissues.
Brain result Positive LRS tissues out
of nine examined
0–3 4–6 7–9
Positive/tested 9*/26 7/15 22/31
% 34.6 46.7 71.0
Signiﬁcance** A AB B
* The nine CNS positive cases associated with low
PrPd in LRS tissues include the four cases without any
PrPd in LRS.
** Percentage values with no letter in common are
signiﬁcantly different (p < 0.05) in the Fisher’s exact
test.
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not detected as infected by the BioRad TeSeE
ELISA. All those 19 ELISA-positive goats
were amongst the cases that were IHC positive
in both LRS and brain samples (Tab. I) and, on
extended examinations, they showed markedly
higher magnitudes of PrPd accumulation in
the brain (Fig. 1a) than did IHC-positive,
ELISA-negative goats (Fig. 1b). All 19 ELISA
positive cases were conﬁrmed on brain samples
by IHC with R145 and by Western blotting
with SHA31 antibodies; three of them were
negative and another three inconclusive for
spongiform pathology.
3.2. Tissue distribution of PrPd
and ante-mortem detection of infection
A high proportion of the scrapie-infected
goats (31/72; 43.1%) accumulated PrPd in 7
or more of the 9 LRS tissues examined, 15
(20.8%) in 4 to 6 LRS tissues, 13 (18.1%) in
2 or 3 LRS samples, and 9 (12.5%) were IHC
positive in a single LRS tissue. PrPd is a marker
of TSE infection and this range of PrPd distribu-
tion suggests that infection in the herd was at
different stages in different animals. Moreover,
there was an association between the spread
of infection within the LRS and the magnitude
of PrPd accumulation in the speciﬁc tissues
involved. Thus, in those cases in which a single
LRS tissue was affected, the amounts of PrPd
were very small, often within a few or even sin-
gle cells resembling tingible body macrophages
(Fig. 2a), while prominent PrPd deposits associ-
ated with both follicular dendritic cells and
tingible body macrophages (Fig. 2b) were fre-
quent in those cases in which the number of
LRS tissues affected was also high.
Within the 72 scrapie-infected goats, the
medial retropharyngeal lymph node (62/71
positive samples; 87.3%) and the palatine tonsil
(60/71; 84.5%) showed a signiﬁcantly higher
frequency of PrPd accumulation than all other
LRS tissues (p < 0.05). In descending order,
the others were the distal jejunal lymph node
(44/72; 61.1%), the nictitating membrane (43/
72; 59.7%), and the pre-scapular lymph node
(39/72; 54.2%), the Peyer’s patches (33/71;
46.5%), the pre-femoral lymph node (33/72;
45.8%), the RAMALT (30/72; 41.7%) and the
spleen (27/72; 37.5%). These last two tissues
showed a signiﬁcantly lower rate of PrPd accu-
mulation than the distal jejunal lymph node
(p < 0.05).
As with the brain, the frequency of PrPd
accumulation in RAMALT samples taken at
post-mortem was correlated to the overall
LRS involvement (Tab. III). Thus, the
probability of a positive result in the RAMALT
increased from an overall 41.7% (30/72) to
69.0% (29/42), 75.0% (27/36) or 84.0% (21/
25), for animals with more than 4, 5 or 6 PrPd
positive LRS tissues – other than the RAMALT
itself –, respectively. A further assessment of
the efﬁciency of PrPd detection in the
RAMALT as a means of identifying preclinical
carriers of infection comes from the results of
the biopsies performed before the goats were
culled. A total of 54 biopsies (26 of RAMALT
and 28 of palatine tonsil) were taken from 36
goats that were TSE negative at post-mortem
examinations, and none of them provided posi-
tive results (100% speciﬁcity). Judged on 26
scrapie-positive goats on post-mortem, the sen-
sitivity of tonsil biopsies was 52.6% (10/19)
and that of RAMALT biopsies was 40.0% (8/
20); the difference was not statistically signiﬁ-
cant. All eight goats with positive RAMALT
biopsy were also PrPd positive in rectal mucosa
taken at post-mortem; only one goat showing
PrPd accumulation in this tissue sample at
post-mortem was negative in biopsy (only two
follicles present in the specimen). Equally, all
10 goats with positive tonsil biopsy result
showed PrPd accumulation in this sample taken
at post-mortem; however, six goats with posi-
tive tonsil at post-mortem had provided nega-
tive biopsy results (1, 7, 9, 9, 16 and 30
follicles present, respectively).
3.3. Effect of age and PNRP genotype on scrapie
prevalence
The age of the infected goats (67.5 months,
95% CI 61.3–73.6) was signiﬁcantly lower
(p < 0.05, Mann–Whitney test) than that of
the non-infected animals (76.5 months,
95% CI 71.7–81.3). These observations were
conﬁrmed by the comparative analysis of two
age cohorts (Tab. IV), so that the Fisher’s exact
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(page number not for citation purpose) Page 5 of 13
test indicated signiﬁcant differences (p = 0.004)
in scrapie prevalence between the youngest
(< 60 months, 50.8%) and the oldest (> 60
months, 29.2%) groups. The split of ages into
younger and older than 60 months was chosen
because no goats aged between 54 and 65
months were included within the 200
examined.
Homozygosity for isoleucine at codon 142
(II142) was linked to scrapie infection. These
goats showed a signiﬁcantly higher prevalence
of infection (40/80; 50.0%) than methionine
homozygotes (MM142; 4/27; 14.8%), and than
IM142 heterozygotes (28/93; 30.1%). The Fish-
er’s exact test showed a signiﬁcantly higher
probability of scrapie infection for the II142
group when compared to the IM142 group
(p < 0.01), to the MM142 group (p = 0.001),
and to the two of them together (p < 0.001).
Signiﬁcant differences were not found between
Figure 2. Accumulation of PrPd in lymphoreticular tissues (retropharyngeal lymph nodes) of scrapie
infected goats. (a) Intracellular deposits (arrow) in single or few cells in the light zone of a single secondary
follicle of a single lymph node were the only indication of infection in some goats. IHC with Bar224 PrP
antibody and haematoxylin counterstaining, ·20. (b) In some other animals, accumulation of PrPd was
widespread and severe with abundant aggregates associated with follicular dendritic cells and tingible body
macrophages. IHC with Bar224 PrP antibody and haematoxylin counterstaining, ·10.
Figure 1. Accumulation of PrPd in the medulla of scrapie infected goats. (a) Abundant deposits of
abnormal protein in the neuropil of the dorsal motor nucleus of the vagus nerve (DMNV) and adjacent
structures, with occasional heavily labelled coalescing PrPd aggregates; serial samples of caudal medulla
provided positive ELISA results. IHC with Bar224 PrP antibody and haematoxylin counterstaining, ·10.
(b) Trace extracellular deposits (arrows) in the DMNV of a clinically healthy goat that provided negative
ELISA results in serial samples of caudal medulla. IHC with Bar224 PrP antibody and haematoxylin
counterstaining, ·20.
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the heterozygotes and the MM142 goats
(p = 0.1), indicating a protective, though
incomplete, effect of methionine at this posi-
tion. Genotypes at this codon were available
for 62 of the 75 scrapie cases conﬁrmed in this
herd prior to the cull. When these were added to
the post-cull data, the link between homozygos-
ity for isoleucine at codon 142 and infection
became even more evident, as 55 of those 62
cases (88.7%) were II142 homozygotes and the
other 7 were IM142 heterozygotes.
The effect of the genotype at codon 142 on
the prevalence of scrapie appeared to be modu-
lated by the age of the animals (Tab. IV). Thus,
in the group younger than 60 months, isoleu-
cine homozygotes and methionine carriers
(IM142 and MM142 together) showed a very
similar probability of infection (57.1% and
47.6%, respectively); in contrast, II142 goats
older than 60 months were much more likely
to be infected than methionine carriers (47.4%
and 15.4%, respectively; p < 0.0001). More-
over, while the probability of infection in iso-
leucine homozygotes did not vary with age,
methionine carriers younger than 60 months
showed a signiﬁcantly higher (p = 0.0002)
prevalence of infection (47.6%) than older ani-
mals of the same genotypes (15.4%). The over-
all age results provided at the beginning of this
section were therefore inﬂuenced by the fact
that two thirds of the youngest goat group were
methionine carriers, while genotypes were more
balanced in the oldest age group.
3.4. Relationship between infection
and clinical disease
Seven of the 200 selected goats were identi-
ﬁed as showing deﬁnite signs of scrapie
(group 3). Thirty animals had inconclusive
signs (group 2), 20 displayed signs of other
unrelated conditions (group 1) and the rest
(143) were considered healthy (group 0). All
seven clinical scrapie suspects were isoleucine
homozygotes at codon 142, and were conﬁrmed
as infected by IHC, although two of them, both
over 96 months of age, lacked detectable PrPd
in the brain, and were positive only in LRS tis-
sues. The other ﬁve showed prominent and
widespread PrPd aggregates in the brain and
were BioRad TeSeE ELISA positive; three of
them were between 47 and 53 months old
and two were older than 96 months.
Differences in prevalence of infection were
absent between groups 0, 1 and 2, with ﬁgures
of 32.1%, 30.0% and 43.3%, respectively.
These values were, however, signiﬁcantly lower
than the 100% observed in the scrapie suspects.
3.5. Discriminatory testing for scrapie and BSE
All but one of the infected goats provided a
PrPd epitope mapping signature of classical
scrapie: intracellular PrPd aggregates, both in
LRS tissues and in the brain (when present),
Table IV. Prevalence of scrapie infection in relation
to the age and genotype of the goats at codon 142
of PrP.
Scrapie result Age cohorts (months) and 142
polymorphism
< 60 > 60
II IM/MM II IM/MM
Positive/tested 12/21 20/42 28/59 12/78
% 57.1 47.6 47.4 15.4
Signiﬁcance* A A A B
* Percentage values with no letter in common are
signiﬁcantly different (p < 0.05) in the Fisher’s exact
test.
Table III. Probability of detection of PrPd in the
RAMALT in relation to the spread of infection in
LRS tissues.
RAMALT
result
Positive LRS tissues out of
8 examined*
0–4 5–6 7–8
Positive/tested 1/30 8/17 21/25
% 3.3 47.1 84.0
Signiﬁcance** A B C
* Excluding the RAMALT itself.
** Percentage values with no letter in common are
signiﬁcantly different (p < 0.05) in the Fisher’s exact
test.
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were immunolabelled with similar intensity by
Bar224 and 12B2 antibodies. For those goats
that were positive in the brain and gave a posi-
tive Bio-Rad ELISA result, these ﬁndings were
corroborated by IHC with R145 and P4 anti-
bodies and by Western blot with SHA31 and
P4 antibodies.
One ELISA-positive, clinically unremark-
able, eight year-old Anglo-Nubian goat, homo-
zygous for isoleucine at codon 142, provided a
protease-resistant PrP Western blot pattern dif-
ferent from the rest, with a lower molecular
weight of the unglycosylated band and a mark-
edly reduced signal with mAb P4. In IHC,
while extracellular PrPd aggregates were
revealed with both Bar224 and 12B2 antibodies
(Figs. 3a and 3b), intraneuronal and intrami-
croglial PrPd deposits in thalamic nuclei, and
in the accessory cuneate, trigeminal and olivary
nuclei of the obex, were prominent with R145
and Bar224 antibodies but were not revealed
at all with either P4 or 12B2 monoclonal anti-
bodies (Figs. 3c and 3d). Therefore, both bio-
chemical and intracellular truncation patterns
of PrPd in brain tissue of this goat were compat-
ible with experimental BSE in small ruminants
[20, 30]. However, in the retropharingeal lymph
node, PrPd aggregates within the cytoplasm of
tingible body macrophages were labelled with
both Bar224 and 12B2 (Figs. 3e and 3f); this
was in contrast with an experimental BSE con-
trol goat lymph node examined in parallel,
which showed no intracellular PrPd with
12B2. Also, all Western blot features, including
the SHA31/P4 signal ratio, of a sample of retro-
pharyngeal lymph node of this goat were those
of scrapie. Moreover, further IHC examinations
in brain sections from this animal, showed no
intracellular immunolabelling with antibodies
9A2 and 1E4, which recognize epitopes more
C-terminally located than that of 12B2. Other
antibodies such as 521, 505 or IDPrP4, which
recognize epitopes in the same regions as 9A2
and 1E4, produced strong intraneuronal signal
in cases of experimental caprine BSE [19].
Routine IHC examinations performed in the
brain of the 200 goats did not show any PrP
accumulation suggestive, either morphologi-
cally or topographically, of Nor98/atypical
scrapie.
4. DISCUSSION
4.1. Implications for surveillance of goat TSE
Scrapie in this goat herd reached a high prev-
alence of infection and a high incidence of clin-
ical disease. This may be due to the intensive
management system of this commercial dairy
herd, where animals were kept at high density
indoors and where husbandry practices, such as
pooling of colostrum andmilk for feeding to kids
and the use of group kidding penswere common.
The extensive range of tissues examined and the
high level of scrutiny allowed detection of cases
where PrPd was restricted to a low number of
cells within a single tissue; it is thus possible that
such low levels of immunoreactivity may have
been missed in some goats. Moreover, the selec-
tion of the 200 goats was biased against isoleu-
cine homozygotes (40.0% amongst the 200
versus 50.0% in a random sample of 298 goats
analyzed in 2007; results not shown). Therefore,
the scrapie prevalence ﬁgure obtained may
underestimate the true level of infection.
While clinical signs of disease were absent
in several animals with widespread PrPd in
brain, deﬁnite signs were observed repeatedly
in two animals without detectable PrPd in
their brains. Lack of correlation of brain PrPd
and clinical signs has been reported in sheep
scrapie [20], and the absence of both indica-
tors of disease in almost half of infected goats
in this study underlines the limits of their use
in monitoring herds for infection.
Current surveillance programmes, where
only samples of brain are examined [26], will
clearly provide a poor estimate of the preva-
lence of scrapie, at least in ﬂocks or herds with
high levels of infection. Previous work had sug-
gested that examination of LRS tissues in addi-
tion to brain provides better estimates of scrapie
infection in sheep [13, 25, 28]. Our results are a
noticeable example that this is also the case in
goats and that, in agreement with those earlier
sheep studies, the medial retropharyngeal
lymph node would be the sample of choice,
together with the obex, for post-mortem surveil-
lance. The relative insensitivity of the rapid
screening test used for statutory purposes in this
study compared to IHC was probably due to the
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very low level of PrPd deposits found, restricted
to the dorsal motor nucleus of the vagus nerve
in some animals, together with the sub-optimal
site of sampling – caudal to the obex – for rapid
testing, imposed by the design of the study. In
addition, it can also be considered that the
BioRad TeSeE assay used for statutory diagno-
sis in these goats can be less sensitive than other
‘‘rapid tests’’ such as the BioRad TeSeE sheep
and goats or the Idexx Herd Chek.
Post-mortem detection of PrPd in the
RAMALT was achieved in a low percentage
Figure 3. Discriminatory immunohistochemistry on an unusual goat TSE case. Extracellular accumulation
of PrPd in the brain was revealed with both Bar224 (a) and 12B2 (b) PrP antibodies. IHC and haematoxylin
counterstaining, ·4. Intraneuronal PrPd deposits in the olivary nucleus were prominent when labelled with
Bar224 (c) but absent when incubated with 12B2 antibody (d). IHC and haematoxylin counterstaining, ·20.
In the retropharyngeal lymph node, however, intracellular PrPd deposits were labelled with both bar224 (e)
and 12B2 (f) antibodies. IHC and haematoxylin counterstaining, ·10.
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(41.7%) of positive goats. This was unexpected
considering previous ﬁgures obtained in pre-
clinical sheep scrapie (86.0%, [13]), and similar
ones in chronic wasting disease of cervids [21,
33]. Whether this is a feature of goat scrapie in
general or a peculiarity of this outbreak is
unknown but, in any case, the frequency of
detection of PrPd in the RAMALT rises to
84.0% when goats with widespread LRS
involvement – but still at preclinical stages –
are considered. Encouragingly, rectal biopsies
for ante-mortem diagnosis of goat scrapie taken
shortly before necropsy gave only slightly, non-
signiﬁcantly inferior results (40.0%) to those of
tonsil biopsies (52.6%). The lower efﬁciency of
tonsil biopsies when compared to post-mortem
values (84.5%) can be due to the proportion
of positive follicles in some tonsil samples
being very small, together with the low num-
bers of follicles in some biopsy specimens.
These sensitivity data can be used to correct
estimates of prevalence of infection based on
RAMALT or palatine tonsil ante-mortem test-
ing to control future goat scrapie outbreaks.
4.2. Risk factors for high prevalence of infection
Following earlier epidemiological observa-
tions reporting a higher risk of scrapie amongst
lambs sucking from infected dams than in those
reared artiﬁcially [7], evidence of scrapie infec-
tivity in sheep milk [24] and of transmission via
sheep milk and/or colostrum has been docu-
mented [23]. Sharing of milk/colostrum and
cross-fostering of animals were frequent prac-
tices within this commercial dairy herd and
may have contributed to the rapid increase of
disease after the diagnosis of the index case in
2005. Around 1 000 L of milk were collected
from scrapie-infected goats of this herd, and
transmission studies are planned to determine
the infectivity of goats milk.
The analysis of the inﬂuence of the polymor-
phism at codon 142 of the caprine PrP has
highlighted some interesting points. Protracted
incubation periods, but no protection in terms
of attack rate, were observed in methionine
carriers at this codon challenged by parenteral
routes with a diversity of TSE agents [10],
while in this study of natural infection, those
polymorphisms appeared to inﬂuence the sus-
ceptibility to infection. Thus, methionine carri-
ers showed a lower overall prevalence than
isoleucine homozygotes, but when doing a
combined analysis together with the age, that
effect was only seen in goats older than 60
months. One possible interpretation (Fig. 4) is
that at the beginning of the scrapie epidemic,
perhaps until 2003 (5 years before the cull took
place), the pressure of infection was relatively
low and mostly isoleucine homozygotes
became infected; this could explain the low
prevalence of scrapie amongst M142 carriers
older than 60 months (15.4%) compared to iso-
leucine homozygotes of the same age range
(47.4%). At that time, and probably helped by
the intensive management imposed, the preva-
lence of infection would have started to rise
exponentially, exerting progressively a pressure
that made young M142 carriers no longer resis-
tant to infection; this would have resulted in
similar prevalence values amongst M142 carriers
(47.6%) and II142 goats (57.1%) younger than
60 months at the time of culling. However, a
higher pressure of infection in recent years
should have also resulted in a higher prevalence
amongst young isoleucine homozygotes, which
was not the case. Two possible explanations are
(i) the disappearance from the herd, due to clin-
ical disease in 2006 and 2007, of a high number
of II142 goats, which would have ﬁtted into that
young age group, and (ii) that  60% preva-
lence amongst isoleucine homozygotes is the
highest ﬁgure that can be reached in natural
conditions, whatever the pressure of infection
may be. In any case, it would appear that inten-
sive management practices leading to high pres-
sure of infection may compromise any attempt
to control scrapie in dairy goat herds by genetic
selection on codon 142; whether or not this also
applies to polymorphisms at other codons
affecting scrapie susceptibility [31] remains to
be established.
4.3. Strain diversity
The detection in this goat herd of a TSE case
with unusual IHC and biochemical features
raised initial concerns, as BSE could not be
excluded. However, further IHC examinations
Vet. Res. (2009) 40:65 L. Gonza´lez et al.
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of the brain and lymphoid tissues revealed fea-
tures different from those of goat BSE, at least
from that experimentally reproduced with
bovine inoculum by the intracerebral route
[19]. This animal may represent a natural case
of mixed infection with two or more strains
and will be further investigated by mouse bioas-
say to improve our understanding of the
diversity of goat TSE. Being able to identify
different natural goat TSE strains, particularly
BSE, is an important issue since goat products,
in particular milk, yoghurt and cheese, could be
potential threats to human health.
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